These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12708596)

  • 61. The epidemiology of equid herpesvirus abortion: a tantalizing mystery.
    Mumford JA
    Equine Vet J; 1991 Mar; 23(2):77-8. PubMed ID: 1646104
    [No Abstract]   [Full Text] [Related]  

  • 62. Isolation of equine herpesvirus type 1 from a horse with an acute paralytic disease.
    Thorsen J; Little PB
    Can J Comp Med; 1975 Jul; 39(3):358-9. PubMed ID: 166741
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outbreak of equine herpesvirus abortion in the Hunter Valley, New South Wales.
    Herbert L; Rodger JA
    Equine Vet J; 1983 Jul; 15(3):276-8. PubMed ID: 6309512
    [No Abstract]   [Full Text] [Related]  

  • 64. [Equine rhinopneumonitis: molecular epidemiology and diagnosis by molecular probes prepared from organs].
    Zientara S; Sailleau C
    Rev Sci Tech; 1993 Jun; 12(2):493-504. PubMed ID: 8400389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Equine rhinopneumonitis outbreak at Newmarket.
    Greenwood RE
    Vet Rec; 1979 Jun; 104(23):534-5. PubMed ID: 224566
    [No Abstract]   [Full Text] [Related]  

  • 66. Pulmonary vasculotropic EHV-1 infection in equids.
    Del Piero F; Wilkins PA
    Vet Pathol; 2001 Jul; 38(4):474. PubMed ID: 11467487
    [No Abstract]   [Full Text] [Related]  

  • 67. Pathogenesis of equine herpesvirus-associated neurological disease: a revised explanation.
    Borchers K; Thein R; Sterner-Kock A
    Equine Vet J; 2006 May; 38(3):283-7. PubMed ID: 16706288
    [No Abstract]   [Full Text] [Related]  

  • 68. [Vaccination against the paralytic form of EHV1?].
    Breukink HJ; Binkhorst GJ; van Oirschot JT
    Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862
    [No Abstract]   [Full Text] [Related]  

  • 69. Equine herpesvirus neurologic disease: reflections from across the pond.
    Kydd JH; Smith KC
    J Vet Intern Med; 2006; 20(3):467-8. PubMed ID: 16734076
    [No Abstract]   [Full Text] [Related]  

  • 70. Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses.
    Friday PA; Scarratt WK; Elvinger F; Timoney PJ; Bonda A
    J Vet Intern Med; 2000; 14(2):197-201. PubMed ID: 10772493
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of an EHV-1 outbreak at FEI events and its international impact.
    Vet Rec; 2021 Sep; 189(5):e905. PubMed ID: 34505682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Another fence jumped in the EHV-1 stakes.
    Edington N
    Equine Vet J; 1994 Nov; 26(6):437-8. PubMed ID: 7889915
    [No Abstract]   [Full Text] [Related]  

  • 74. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Neurologic form of rhinopneumonia].
    Sloet van Oldruitenborgh-Oosterbaan M
    Tijdschr Diergeneeskd; 2005 Oct; 130(20):629-31. PubMed ID: 16276730
    [No Abstract]   [Full Text] [Related]  

  • 76. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro neutralization of equid herpesvirus 1 mediated by recombinant antibodies.
    Molinková D; Skládal P; Celer V
    J Immunol Methods; 2008 Apr; 333(1-2):186-91. PubMed ID: 18329664
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deadly viral outbreak ravages European horses.
    Lesté-Lasserre C
    Science; 2021 Mar; 371(6536):1297. PubMed ID: 33766865
    [No Abstract]   [Full Text] [Related]  

  • 80. Detection of equine herpesvirus type 1 by real time PCR.
    Elia G; Decaro N; Martella V; Campolo M; Desario C; Lorusso E; Cirone F; Buonavoglia C
    J Virol Methods; 2006 Apr; 133(1):70-5. PubMed ID: 16309751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.